|
GB581334A
(en)
|
1943-09-29 |
1946-10-09 |
Francis Henry Swinden Curd |
New pyrimidine compounds
|
|
JPS4921148B1
(enExample)
|
1970-12-28 |
1974-05-30 |
|
|
|
JPS4921149B1
(enExample)
|
1970-12-28 |
1974-05-30 |
|
|
|
AT340933B
(de)
|
1973-08-20 |
1978-01-10 |
Thomae Gmbh Dr K |
Verfahren zur herstellung neuer pyrimidinderivate und ihrer saureadditionssalze
|
|
DE2341925A1
(de)
|
1973-08-20 |
1975-03-06 |
Thomae Gmbh Dr K |
Neue pyrimidinderivate und verfahren zu ihrer herstellung
|
|
US4994386A
(en)
|
1987-07-13 |
1991-02-19 |
Pharmacia Diagnostics, Inc. |
Production of HBLV virus in the HSB-2 cell line
|
|
US4929726A
(en)
|
1988-02-09 |
1990-05-29 |
Georgia State University Foundation, Inc. |
Novel diazines and their method of preparation
|
|
EP0330263A1
(en)
|
1988-02-25 |
1989-08-30 |
Merck & Co. Inc. |
Piperazinylalkylpyrimidines as hypoglycemic agents
|
|
GB9012311D0
(en)
|
1990-06-01 |
1990-07-18 |
Wellcome Found |
Pharmacologically active cns compounds
|
|
KR950007756B1
(ko)
|
1990-07-03 |
1995-07-14 |
미쓰이세끼유 가가꾸고오교오 가부시끼가이샤 |
피리미딘 화합물 및 그의 약학적으로 허용되는 염류
|
|
HUP9603433A3
(en)
|
1995-04-13 |
1998-04-28 |
Taiho Pharmaceutical Co Ltd |
4-6-diaryl-pyrimidine-derivatives, process for producing them and pharmaceutical compositions containing them
|
|
JP3734907B2
(ja)
|
1996-12-19 |
2006-01-11 |
富士写真フイルム株式会社 |
現像処理方法
|
|
DK1020462T3
(da)
|
1997-07-24 |
2004-04-26 |
Zenyaku Kogyo Kk |
Heterocykliske forbindelser og antitumormiddel indeholdende disse som aktiv ingrediens
|
|
JPH11158073A
(ja)
|
1997-09-26 |
1999-06-15 |
Takeda Chem Ind Ltd |
アデノシンａ３拮抗剤
|
|
US6440965B1
(en)
|
1997-10-15 |
2002-08-27 |
Krenitsky Pharmaceuticals, Inc. |
Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
|
|
US6150362A
(en)
|
1997-12-12 |
2000-11-21 |
Henkin; Jack |
Triazine angiogenesis inhibitors
|
|
EP0930302B1
(en)
|
1998-01-16 |
2003-04-02 |
F.Hoffmann-La Roche Ag |
Benzosulfone derivatives
|
|
CN1312807A
(zh)
|
1998-06-19 |
2001-09-12 |
希龙公司 |
糖元合成酶激酶3的抑制剂
|
|
US7045519B2
(en)
|
1998-06-19 |
2006-05-16 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
|
JP2002535318A
(ja)
|
1999-01-22 |
2002-10-22 |
アムジエン・インコーポレーテツド |
キナーゼ阻害薬
|
|
US6495558B1
(en)
|
1999-01-22 |
2002-12-17 |
Amgen Inc. |
Kinase inhibitors
|
|
WO2001000207A1
(en)
|
1999-06-30 |
2001-01-04 |
Merck & Co., Inc. |
Src kinase inhibitor compounds
|
|
US6316444B1
(en)
|
1999-06-30 |
2001-11-13 |
Merck & Co., Inc. |
SRC kinase inhibitor compounds
|
|
DE60006541D1
(de)
|
1999-06-30 |
2003-12-18 |
Merck & Co Inc |
Src-kinase hemmende verbindungen
|
|
DE60005355T2
(de)
|
1999-07-15 |
2004-07-01 |
Pharmacopeia, Inc. |
Bradikinin b1 rezeptor antagonisten
|
|
JP2001089452A
(ja)
|
1999-09-22 |
2001-04-03 |
Sankyo Co Ltd |
ピリミジン誘導体
|
|
MXPA02007957A
(es)
|
2000-02-17 |
2002-11-29 |
Amgen Inc |
Inhibidores de cinasas.
|
|
HUP0300382A3
(en)
|
2000-03-29 |
2006-11-28 |
Cyclacel Ltd |
2-substituted 4-heteroaryl-pyrimidines and their use in the treatmetn of proliferative disorders and pharmaceutical compositions containing the compounds
|
|
CN100345830C
(zh)
|
2000-04-27 |
2007-10-31 |
安斯泰来制药有限公司 |
稠合杂芳基衍生物
|
|
MXPA02010693A
(es)
|
2000-04-28 |
2003-03-10 |
Tanabe Seiyaku Co |
Compuestos ciclicos.
|
|
AU2001268711A1
(en)
|
2000-06-23 |
2002-01-08 |
Bristol-Myers Squibb Pharma Company |
Heteroaryl-phenyl substituted factor xa inhibitors
|
|
WO2002020495A2
(en)
|
2000-09-06 |
2002-03-14 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
|
DK1318997T3
(da)
|
2000-09-15 |
2006-09-25 |
Vertex Pharma |
Pyrazolforbindelser der er nyttige som proteinkinase-inhibitorer
|
|
SE0004053D0
(sv)
|
2000-11-06 |
2000-11-06 |
Astrazeneca Ab |
N-type calcium channel antagonists for the treatment of pain
|
|
HUP0400639A3
(en)
|
2000-12-21 |
2010-03-29 |
Vertex Pharma |
Pyrazole compounds useful as protein kinase inhibitors and pharmaceutical compositions containing them
|
|
EP1363890A4
(en)
|
2001-02-07 |
2009-06-10 |
Ore Pharmaceuticals Inc |
MELANOCORTIN-4-RECEPTOR BINDING COMPOUNDS AND METHOD FOR THEIR APPLICATION
|
|
AU2002258400A1
(en)
|
2001-02-16 |
2002-08-28 |
Tularik Inc. |
Methods of using pyrimidine-based antiviral agents
|
|
JP2004531571A
(ja)
|
2001-05-25 |
2004-10-14 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
サイトカイン生産のインヒビターとしてのカルバメート及びオキサミド化合物
|
|
HUP0402352A2
(hu)
|
2001-06-19 |
2005-02-28 |
Bristol-Myers Squibb Co. |
Foszfodiészteráz (PDE) 7 inhibitorként alkalmazható pirimidinszármazékok és ezeket tartalmazó gyógyszerkészítmények
|
|
US6603000B2
(en)
|
2001-07-11 |
2003-08-05 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Synthesis for heteroarylamine compounds
|
|
WO2003030909A1
(en)
|
2001-09-25 |
2003-04-17 |
Bayer Pharmaceuticals Corporation |
2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
|
|
EP1485100B1
(en)
|
2002-03-15 |
2010-05-05 |
Vertex Pharmaceuticals Incorporated |
Azinylaminoazoles as inhibitors of protein kinases
|
|
ES2289279T3
(es)
|
2002-03-15 |
2008-02-01 |
Vertex Pharmaceuticals Incorporated |
Composiciones utiles como inhibidores de proteinquinasas.
|
|
ATE433973T1
(de)
|
2002-03-15 |
2009-07-15 |
Vertex Pharma |
Azolylaminoazine als inhibitoren von proteinkinasen
|
|
ATE468336T1
(de)
|
2002-03-15 |
2010-06-15 |
Vertex Pharma |
Azolylaminoazine als proteinkinasehemmer
|
|
WO2004000820A2
(en)
|
2002-06-21 |
2003-12-31 |
Cellular Genomics, Inc. |
Certain aromatic monocycles as kinase modulators
|
|
WO2004029204A2
(en)
|
2002-09-27 |
2004-04-08 |
Merck & Co., Inc. |
Substituted pyrimidines
|
|
US20040171073A1
(en)
|
2002-10-08 |
2004-09-02 |
Massachusetts Institute Of Technology |
Compounds for modulation of cholesterol transport
|
|
US7223870B2
(en)
|
2002-11-01 |
2007-05-29 |
Pfizer Inc. |
Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction
|
|
ES2412273T3
(es)
|
2002-11-21 |
2013-07-10 |
Novartis Ag |
Inhibidores de 2-morfolín-4-pirimidinas como inhibidores de fosfotidilinositol (PI) 3-quinasa y su uso en el tratamiento del cáncer.
|
|
CA2514733A1
(en)
|
2003-02-28 |
2004-09-16 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
|
US20060293339A1
(en)
|
2003-03-24 |
2006-12-28 |
Chakravarty Prasun K |
Biaryl substituted 6-membered heterocycles as sodium channel blockers
|
|
US20050014753A1
(en)
|
2003-04-04 |
2005-01-20 |
Irm Llc |
Novel compounds and compositions as protein kinase inhibitors
|
|
JP4895806B2
(ja)
|
2003-04-09 |
2012-03-14 |
エクセリクシス， インク． |
Ｔｉｅ−２モジュレータと使用方法
|
|
JP2007523875A
(ja)
|
2003-07-15 |
2007-08-23 |
ニューロジェン・コーポレーション |
バニロイド受容体リガンドとしての置換ピリミジン−４−イルアミン類縁体
|
|
AU2004257289A1
(en)
|
2003-07-16 |
2005-01-27 |
Neurogen Corporation |
Biaryl piperazinyl-pyridine analogues
|
|
AR045944A1
(es)
*
|
2003-09-24 |
2005-11-16 |
Novartis Ag |
Derivados de isoquinolina 1.4-disustituidas
|
|
US7560464B2
(en)
|
2004-04-13 |
2009-07-14 |
Icagen, Inc. |
Polycyclic pyrimidines as potassium ion channel modulators
|
|
GB0415365D0
(en)
|
2004-07-09 |
2004-08-11 |
Astrazeneca Ab |
Pyrimidine derivatives
|
|
GB0415364D0
(en)
|
2004-07-09 |
2004-08-11 |
Astrazeneca Ab |
Pyrimidine derivatives
|
|
MY145822A
(en)
|
2004-08-13 |
2012-04-30 |
Neurogen Corp |
Substituted biaryl piperazinyl-pyridine analogues
|
|
JP2008521900A
(ja)
*
|
2004-11-30 |
2008-06-26 |
アムジエン・インコーポレーテツド |
キノリン及びキナゾリン類似体並びにがん治療のための医薬としてのその使用
|
|
CA2590299A1
(en)
|
2004-12-13 |
2006-06-22 |
Neurogen Corporation |
Piperazinyl-pyridine analogues
|
|
US20080132509A1
(en)
|
2004-12-13 |
2008-06-05 |
Neurogen Corporation |
Substituted Biaryl Analogues
|
|
WO2006071960A2
(en)
|
2004-12-28 |
2006-07-06 |
Kinex Pharmaceuticals, Llc |
Compositions and methods of treating cell proliferation disorders
|
|
EP1838703A2
(en)
|
2005-01-19 |
2007-10-03 |
Neurogen Corporation |
Heteroaryl substituted piperazinyl-pyridine analogues
|
|
MX2007010404A
(es)
|
2005-02-25 |
2008-01-11 |
Kudos Pharm Ltd |
Hidrazinometilo, hidrazonometilo y compuestos heterociclicos de 5 miembros que actuan como inhibidores de mtor y su uso como agentes anti-cancer.
|
|
EP1871762A2
(en)
|
2005-04-18 |
2008-01-02 |
Neurogen Corporation |
Subtituted heteroaryl cb1 antagonists
|
|
GB2431156A
(en)
|
2005-10-11 |
2007-04-18 |
Piramed Ltd |
1-cyclyl-3-substituted- -benzenes and -azines as inhibitors of phosphatidylinositol 3-kinase
|
|
BRPI0706395A2
(pt)
|
2006-01-11 |
2011-03-22 |
Astrazeneca Ab |
composto, uso do mesmo, métodos para produzir um efeito anti-proliferativo em um animal de sangue quente e para tratar doença, composição farmacêutica, e, processo para preparar um composto
|
|
JO2660B1
(en)
*
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
|
WO2007120897A2
(en)
*
|
2006-04-13 |
2007-10-25 |
The Trustees Of Columbia University In The City Of New York |
Compositions and intraluminal devices for inhibiting vascular stenosis
|
|
CL2007003847A1
(es)
|
2006-12-28 |
2008-04-18 |
Basf Ag |
Compuestos derivados de pirimidinas 2,4,5 tri-sustituidas; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento del cancer.
|
|
ES2381895T3
(es)
|
2007-02-06 |
2012-06-01 |
Novartis Ag |
Inhibidores de PI 3-quinasa y métodos para su uso
|
|
US7957951B2
(en)
|
2007-03-16 |
2011-06-07 |
Robert Bosch Gmbh |
Address translation system for use in a simulation environment
|
|
CN101801962A
(zh)
|
2007-07-09 |
2010-08-11 |
阿斯利康(瑞典)有限公司 |
用于治疗增殖疾病的三取代嘧啶衍生物
|
|
WO2009066084A1
(en)
|
2007-11-21 |
2009-05-28 |
F. Hoffmann-La Roche Ag |
2 -morpholinopyrimidines and their use as pi3 kinase inhibitors
|
|
EP2259800B1
(en)
|
2008-03-05 |
2014-05-07 |
Novartis AG |
Use of 5-(2,6-di-morpholin-4-yl-pyrimidin-4-yl)-4-trifluoromethyl-pyridin-2-ylamine for the treatment of non small cell lung carcinoma with acquired resistance to epidermal growth factor receptor (EGFR) modulators.
|
|
JP5519627B2
(ja)
|
2008-03-26 |
2014-06-11 |
ノバルティス アーゲー |
Ｖｅｇｆ促進性血管新生過程の強力なモジュレーターとしての５イミダゾキノリン誘導体およびピリミジン誘導体
|
|
US20110053907A1
(en)
|
2008-03-27 |
2011-03-03 |
Auckland Uniservices Limited |
Substituted pyrimidines and triazines and their use in cancer therapy
|
|
WO2009125870A1
(en)
|
2008-04-09 |
2009-10-15 |
Mitsubishi Tanabe Pharma Corporation |
Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers.
|
|
GB0815369D0
(en)
|
2008-08-22 |
2008-10-01 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
|
BRPI0921802A8
(pt)
|
2008-10-31 |
2018-03-13 |
Novartis Ag |
uso de um inibidor de fosfatidilinositol-3-cinase (pi3k) e um inibidor de mtor,bem como composição e combinação farmacêuticas os compreendendo.
|
|
GB2465405A
(en)
|
2008-11-10 |
2010-05-19 |
Univ Basel |
Triazine, pyrimidine and pyridine analogues and their use in therapy
|
|
US8513242B2
(en)
|
2008-12-12 |
2013-08-20 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Pyrimidine compounds and methods of making and using same
|
|
PT2394999E
(pt)
|
2009-02-06 |
2014-05-02 |
Nippon Shinyaku Co Ltd |
Derivado de aminopirazina e medicamento correspondente
|
|
JP5747440B2
(ja)
|
2009-02-06 |
2015-07-15 |
住友化学株式会社 |
ヒドラジド化合物及びその有害生物防除用途
|
|
JP6067226B2
(ja)
|
2009-03-13 |
2017-01-25 |
アジオス ファーマシューティカルズ， インコーポレイテッド |
細胞増殖関連疾患のための方法および組成物
|
|
WO2010120994A2
(en)
|
2009-04-17 |
2010-10-21 |
Wyeth Llc |
Ureidoaryl-and carbamoylaryl-morpholino- pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesis
|
|
NZ596123A
(en)
|
2009-05-19 |
2014-08-29 |
Dow Agrosciences Llc |
Compounds and methods for controlling fungi
|
|
US8486939B2
(en)
|
2009-07-07 |
2013-07-16 |
Pathway Therapeutics Inc. |
Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
|
|
EP2462123B1
(en)
|
2009-08-04 |
2013-10-02 |
Merck Sharp & Dohme Corp. |
4,5,6-trisubstituted pyrimidine derivatives as factor ixa inhibitors
|
|
AR077999A1
(es)
|
2009-09-02 |
2011-10-05 |
Vifor Int Ag |
Antagonistas de pirimidin y triazin-hepcidina
|
|
WO2011031896A2
(en)
|
2009-09-09 |
2011-03-17 |
Avila Therapeutics, Inc. |
Pi3 kinase inhibitors and uses thereof
|
|
EP2509600B1
(en)
|
2009-12-09 |
2017-08-02 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds for use in the treatment of cancer characterized as having an idh mutation
|
|
GB201004200D0
(en)
|
2010-03-15 |
2010-04-28 |
Univ Basel |
Spirocyclic compounds and their use as therapeutic agents and diagnostic probes
|
|
WO2011133920A1
(en)
|
2010-04-23 |
2011-10-27 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
|
AR081626A1
(es)
|
2010-04-23 |
2012-10-10 |
Cytokinetics Inc |
Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
|
|
AR081331A1
(es)
|
2010-04-23 |
2012-08-08 |
Cytokinetics Inc |
Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
|
|
US20130109643A1
(en)
|
2010-05-10 |
2013-05-02 |
The Johns Hopkins University |
Metabolic inhibitor against tumors having an idh mutation
|
|
WO2012009678A1
(en)
|
2010-07-16 |
2012-01-19 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compositions and their method of use
|
|
CA2813333C
(en)
|
2010-10-01 |
2019-01-15 |
Novartis Ag |
Manufacturing process for pyrimidine derivatives
|
|
ES2646835T3
(es)
|
2010-10-18 |
2017-12-18 |
Cerenis Therapeutics Holding Sa |
Compuestos, composiciones y procedimientos útiles para la movilización del colesterol
|
|
GB201106829D0
(en)
|
2011-04-21 |
2011-06-01 |
Proximagen Ltd |
Heterocyclic compounds
|
|
EP2673268A1
(en)
|
2011-02-11 |
2013-12-18 |
Dana-Farber Cancer Institute, Inc. |
Method of inhibiting hamartoma tumor cells
|
|
CN102827073A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
|
WO2013030368A1
(en)
|
2011-09-01 |
2013-03-07 |
Novartis Ag |
Pi3k inhibitor for use in the treatment of bone cancer or for preventing metastatic dissemination primary cancer cells into the bone
|
|
EP2771337B1
(en)
|
2011-09-27 |
2017-08-02 |
Novartis AG |
3-(pyrimidin-4-yl)-oxazolidin-2-ones as inhibitors of mutant idh
|
|
CA2851082A1
(en)
|
2011-10-06 |
2013-04-11 |
Merck Sharp & Dohme Corp. |
1,3-substituted azetidine pde10 inhibitors
|
|
UY34632A
(es)
|
2012-02-24 |
2013-05-31 |
Novartis Ag |
Compuestos de oxazolidin- 2- ona y usos de los mismos
|
|
BR112014028420A2
(pt)
*
|
2012-05-16 |
2017-09-19 |
Novartis Ag |
regime de dosagem para um inibidor de quinase pi-3
|
|
WO2013184621A1
(en)
|
2012-06-06 |
2013-12-12 |
Novartis Ag |
Combination of a 17 -alpha -hydroxylase (c17, 20 - lyase) inhibitor and a specific pi-3k inhibitor for treating a tumor disease
|
|
HK1211476A1
(en)
|
2012-08-16 |
2016-05-27 |
Novartis Ag |
Combination of pi3k inhibitor and c-met inhibitor
|
|
EP2912030B1
(en)
|
2012-10-23 |
2016-08-31 |
Novartis AG |
Improved process for manufacturing 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine
|
|
US9296733B2
(en)
|
2012-11-12 |
2016-03-29 |
Novartis Ag |
Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
|
|
BR112015022483A2
(pt)
|
2013-03-14 |
2017-07-18 |
Novartis Ag |
3-pirimidin-4-il-oxazolidin-2-onas como inibidores de idh mutante
|
|
WO2014141104A1
(en)
|
2013-03-14 |
2014-09-18 |
Novartis Ag |
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
|
|
CN103483345B
(zh)
|
2013-09-25 |
2016-07-06 |
中山大学 |
Pi3k激酶抑制剂、包含其的药物组合物及其应用
|
|
CN103694218B
(zh)
|
2013-12-05 |
2016-04-27 |
中山大学 |
嘧啶化合物、pi3k抑制剂、包含pi3k抑制剂的药物组合物及应用
|